4//SEC Filing
Johnson Kevin C 4
Accession 0001077183-21-000259
CIK 0001077183other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:25 PM ET
Size
10.3 KB
Accession
0001077183-21-000259
Insider Transaction Report
Form 4
Johnson Kevin C
Director
Transactions
- Exercise/Conversion
Common Stock
2021-12-22$7.27/sh+3,334$24,238→ 37,398 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-12-22−3,334→ 0 totalExercise: $7.27Exp: 2022-05-25→ Common Stock (3,334 underlying)
Holdings
- 4,269
Stock Options (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying) - 3,714
Stock Options (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - 3,448
Stock Options (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying)
Footnotes (1)
- [F1]On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001353436
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 5:25 PM ET
- Size
- 10.3 KB